{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:31:24Z","timestamp":1791855084402,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11407-2","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T09:20:02Z","timestamp":1756113602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Molecular epidemiology and clinical patterns of Epstein\u2013Barr virus infection in Southwestern Saudi Arabia: a 2020\u20132023 retrospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Shaqraa","family":"Musawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Zalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Aqeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah","family":"Maha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Abutawail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah A.","family":"Garn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Wasili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Othman","family":"Shageri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Shrefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha Y.","family":"Hifthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tareq","family":"Khawaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman A.","family":"Muhajir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Klufah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz H.","family":"Alhazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousa","family":"Mobarki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"key":"11407_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"283","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM. Virus Particles in Cultured Lymphoblasts from Burkitt\u2019s Lymphoma. Lancet. 1964;283:702\u20133.","journal-title":"Lancet"},{"key":"11407_CR2","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1038\/cti.2014.27","volume":"4","author":"JI Cohen","year":"2015","unstructured":"Cohen JI. Epstein\u2013barr virus vaccines. Clin Transl Immunol. 2015;4:e32.","journal-title":"Clin Transl Immunol"},{"key":"11407_CR3","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004;4:757\u201368.","journal-title":"Nat Rev Cancer"},{"key":"11407_CR4","doi-asserted-by":"publisher","first-page":"1178122X1773177","DOI":"10.1177\/1178122X17731772","volume":"8","author":"D Esau","year":"2017","unstructured":"Esau D. Viral causes of lymphoma: the history of Epstein-Barr virus and human T-Lymphotropic virus 1. Virol Res Treat. 2017;8:1178122X17731772.","journal-title":"Virol Res Treat"},{"key":"11407_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-9378-9-38","volume":"9","author":"G Khan","year":"2014","unstructured":"Khan G, Hashim MJ. Global burden of deaths from Epstein-Barr virus attributable malignancies 1990\u20132010. Infect Agent Cancer. 2014;9:38.","journal-title":"Infect Agent Cancer"},{"key":"11407_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG. Epstein\u2013Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16:789\u2013802.","journal-title":"Nat Rev Cancer"},{"key":"11407_CR7","doi-asserted-by":"publisher","unstructured":"Shannon-Lowe C, Rickinson A. The global landscape of EBV-Associated tumors. Front Oncol. 2019;9:713. https:\/\/doi.org\/10.3389\/fonc.2019.00713.","DOI":"10.3389\/fonc.2019.00713"},{"key":"11407_CR8","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296\u2013301.","journal-title":"Science"},{"key":"11407_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM. Epstein\u2013Barr virus and multiple sclerosis. Nat Rev Microbiol. 2023;21:51\u201364.","journal-title":"Nat Rev Microbiol"},{"key":"11407_CR10","doi-asserted-by":"publisher","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","volume":"8","author":"JB Dowd","year":"2013","unstructured":"Dowd JB, Palermo T, Brite J, McDade TW, Aiello A. Seroprevalence of Epstein-Barr virus infection in U.S. Children ages 6\u201319, 2003\u20132010. PLoS ONE. 2013;8:e64921.","journal-title":"PLoS ONE"},{"key":"11407_CR11","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/infdis\/jit321","volume":"208","author":"HH Balfour Jr","year":"2013","unstructured":"Balfour HH Jr, et al. Age-Specific prevalence of Epstein\u2013Barr virus infection among individuals aged 6\u201319 years in the united States and factors affecting its acquisition. J Infect Dis. 2013;208:1286\u201393.","journal-title":"J Infect Dis"},{"key":"11407_CR12","doi-asserted-by":"publisher","unstructured":"Winter JR et al. Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature. J Glob Health. 2020;10(1):010404. https:\/\/doi.org\/10.7189\/jogh.10.010404.","DOI":"10.7189\/jogh.10.010404"},{"key":"11407_CR13","doi-asserted-by":"publisher","first-page":"e1004746","DOI":"10.1371\/journal.ppat.1004746","volume":"11","author":"S Jayasooriya","year":"2015","unstructured":"Jayasooriya S, et al. Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children. PLoS Pathog. 2015;11:e1004746.","journal-title":"PLoS Pathog"},{"key":"11407_CR14","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","volume":"33","author":"GS Taylor","year":"2015","unstructured":"Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr Virus\u2013Induced disease. Annu Rev Immunol. 2015;33:787\u2013821.","journal-title":"Annu Rev Immunol"},{"key":"11407_CR15","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","volume":"103","author":"K Kawamoto","year":"2018","unstructured":"Kawamoto K, et al. A distinct subtype of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features. Haematologica. 2018;103:1018\u201328.","journal-title":"Haematologica"},{"key":"11407_CR16","doi-asserted-by":"publisher","first-page":"fmaa121","DOI":"10.1093\/tropej\/fmaa121","volume":"67","author":"A Zaki","year":"2021","unstructured":"Zaki A. Primary Epstein\u2013Barr virus infection in healthy children in Saudi arabia: A single Hospital-Based study. J Trop Pediatr. 2021;67:fmaa121.","journal-title":"J Trop Pediatr"},{"key":"11407_CR17","doi-asserted-by":"publisher","first-page":"5818","DOI":"10.1182\/blood-2019-131323","volume":"134","author":"ARZ Zaidi","year":"2019","unstructured":"Zaidi ARZ, et al. Very high Seroprevalence of CMV and EBV among a large series of patients with hematological malignancies at a tertiary care center in Saudi Arabia - a case for investigating cooperativity of viruses in carcinogenesis?? Blood. 2019;134:5818\u20135818.","journal-title":"Blood"},{"key":"11407_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein\u2013Barr virus infection. N Engl J Med. 2000;343:481\u201392.","journal-title":"N Engl J Med"},{"key":"11407_CR19","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1038\/cti.2015.1","volume":"4","author":"HH Balfour Jr","year":"2015","unstructured":"Balfour HH Jr, Dunmire SK, Hogquist KA. Infectious mononucleosis. Clin Transl Immunol. 2015;4:e33.","journal-title":"Clin Transl Immunol"},{"key":"11407_CR20","doi-asserted-by":"publisher","unstructured":"Kimura H, Kwong Y-L. EBV viral loads in diagnosis, monitoring, and response assessment. Front Oncol. 2019;9:62. https:\/\/doi.org\/10.3389\/fonc.2019.00062.","DOI":"10.3389\/fonc.2019.00062"},{"key":"11407_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/pathogens9030226","volume":"9","author":"MAH Abusalah","year":"2020","unstructured":"Abusalah MAH, et al. Recent advances in diagnostic approaches for Epstein\u2013Barr virus. Pathogens. 2020;9:226.","journal-title":"Pathogens"},{"key":"11407_CR22","doi-asserted-by":"publisher","first-page":"e99857","DOI":"10.1371\/journal.pone.0099857","volume":"9","author":"G Xiong","year":"2014","unstructured":"Xiong G, et al. Epstein-Barr virus (EBV) infection in Chinese children: A retrospective study of Age-Specific prevalence. PLoS ONE. 2014;9:e99857.","journal-title":"PLoS ONE"},{"key":"11407_CR23","doi-asserted-by":"publisher","first-page":"e0189033","DOI":"10.1371\/journal.pone.0189033","volume":"12","author":"MK Smatti","year":"2017","unstructured":"Smatti MK, et al. Prevalence and molecular profiling of epstein barr virus (EBV) among healthy blood donors from different nationalities in Qatar. PLoS ONE. 2017;12:e0189033.","journal-title":"PLoS ONE"},{"key":"11407_CR24","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1038\/s41598-021-90351-y","volume":"11","author":"T Chen","year":"2021","unstructured":"Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein\u2013Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11:10902.","journal-title":"Sci Rep"},{"key":"11407_CR25","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/pathogens10060763","volume":"10","author":"JE Gold","year":"2021","unstructured":"Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10:763.","journal-title":"Pathogens"},{"key":"11407_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijid.2020.12.051","volume":"104","author":"S Paolucci","year":"2021","unstructured":"Paolucci S, et al. EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count. Int J Infect Dis. 2021;104:315\u20139.","journal-title":"Int J Infect Dis"},{"key":"11407_CR27","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1177\/08850666211053990","volume":"37","author":"J-H Naendrup","year":"2022","unstructured":"Naendrup J-H, et al. Reactivation of EBV and CMV in severe COVID-19\u2014Epiphenomena or trigger of hyperinflammation in need of treatment?? A large case series of critically ill patients. J Intensive Care Med. 2022;37:1152\u20138.","journal-title":"J Intensive Care Med"},{"key":"11407_CR28","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3390\/v14091872","volume":"14","author":"B Brooks","year":"2022","unstructured":"Brooks B, et al. Epstein\u2013Barr virus and human Herpesvirus-6 reactivation in acute COVID-19 patients. Viruses. 2022;14:1872.","journal-title":"Viruses"},{"key":"11407_CR29","doi-asserted-by":"publisher","first-page":"e597","DOI":"10.1002\/iid3.597","volume":"10","author":"M Meng","year":"2022","unstructured":"Meng M, et al. COVID-19 associated EBV reactivation and effects of ganciclovir treatment. Immun Inflamm Dis. 2022;10:e597.","journal-title":"Immun Inflamm Dis"},{"key":"11407_CR30","doi-asserted-by":"publisher","first-page":"199157","DOI":"10.1016\/j.virusres.2023.199157","volume":"334","author":"KDE Bernal","year":"2023","unstructured":"Bernal KDE, Whitehurst CB. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. Virus Res. 2023;334:199157.","journal-title":"Virus Res"},{"key":"11407_CR31","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1038\/s41380-023-02161-5","volume":"28","author":"K Hashimoto","year":"2023","unstructured":"Hashimoto K. Detrimental effects of COVID-19 in the brain and therapeutic options for long COVID: the role of Epstein\u2013Barr virus and the gut\u2013brain axis. Mol Psychiatry. 2023;28:4968\u201376.","journal-title":"Mol Psychiatry"},{"key":"11407_CR32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1186\/s12879-019-4578-y","volume":"19","author":"JR Winter","year":"2019","unstructured":"Winter JR, et al. Predictors of Epstein-Barr virus serostatus in young people in England. BMC Infect Dis. 2019;19:1007.","journal-title":"BMC Infect Dis"},{"key":"11407_CR33","doi-asserted-by":"publisher","first-page":"1139068","DOI":"10.3389\/fcimb.2023.1139068","volume":"13","author":"Z Ye","year":"2023","unstructured":"Ye Z, et al. Epidemiology and clinical characteristics of Epstein-Barr virus infection among children in shanghai, china, 2017\u20132022. Front Cell Infect Microbiol. 2023;13:1139068.","journal-title":"Front Cell Infect Microbiol"},{"key":"11407_CR34","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.3390\/cancers15245739","volume":"15","author":"C M\u00fcnz","year":"2023","unstructured":"M\u00fcnz C. Modulation of Epstein-Barr-Virus (EBV)-Associated cancers by Co-Infections. Cancers. 2023;15:5739.","journal-title":"Cancers"},{"key":"11407_CR35","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/v14081823","volume":"14","author":"F Nazim","year":"2022","unstructured":"Nazim F, Kayani HA, Ali Nathwani A, Mir F, Abidi SH. CMV and EBV Co-Infection in HIV-Infected children: infection rates and analysis of differential expression of cytokines in HIV Mono- and HIV\u2013CMV\u2013EBV Co-Infected groups. Viruses. 2022;14:1823.","journal-title":"Viruses"},{"key":"11407_CR36","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania B, Kenney SC. Raab-Traub, N. Epstein-Barr virus: biology and clinical disease. Cell. 2022;185:3652\u201370.","journal-title":"Cell"},{"key":"11407_CR37","doi-asserted-by":"publisher","first-page":"1059133","DOI":"10.3389\/fimmu.2022.1059133","volume":"13","author":"S Chakravorty","year":"2022","unstructured":"Chakravorty S, Afzali B, Kazemian M. EBV-associated diseases: current therapeutics and emerging technologies. Front Immunol. 2022;13:1059133.","journal-title":"Front Immunol"},{"key":"11407_CR38","doi-asserted-by":"publisher","first-page":"e2024042","DOI":"10.4084\/MJHID.2024.042","volume":"16","author":"P Tralongo","year":"2024","unstructured":"Tralongo P, Bakacs A, Larocca LM. EBV-Related lymphoproliferative diseases: A review in light of new classifications. Mediterr J Hematol Infect Dis. 2024;16:e2024042.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"11407_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13:82.","journal-title":"Blood Cancer J"},{"key":"11407_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi H, et al. Global burden of liver disease: 2023 update. J Hepatol. 2023;79:516\u201337.","journal-title":"J Hepatol"},{"key":"11407_CR41","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1080\/10428190500286879","volume":"47","author":"K Al-Kuraya","year":"2006","unstructured":"Al-Kuraya K, et al. Epstein-Barr virus infection is not the sole cause of high prevalence for hodgkin\u2019s lymphoma in Saudi Arabia. Leuk Lymphoma. 2006;47:707\u201313.","journal-title":"Leuk Lymphoma"},{"key":"11407_CR42","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00439-020-02145-3","volume":"139","author":"SG Tangye","year":"2020","unstructured":"Tangye SG. Genetic susceptibility to EBV infection: insights from inborn errors of immunity. Hum Genet. 2020;139:885\u2013901.","journal-title":"Hum Genet"},{"key":"11407_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jmv.24633","volume":"89","author":"M Neves","year":"2017","unstructured":"Neves M, Marinho-Dias J, Ribeiro J, Sousa H. Epstein-Barr virus strains and variations: geographic or disease-specific variants? J Med Virol. 2017;89:373\u201387.","journal-title":"J Med Virol"},{"key":"11407_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/cid\/ciu342","volume":"59","author":"LM Condon","year":"2014","unstructured":"Condon LM, et al. Age-Specific prevalence of Epstein-Barr virus infection among Minnesota children: effects of race\/ethnicity and family environment. Clin Infect Dis. 2014;59:501\u20138.","journal-title":"Clin Infect Dis"},{"key":"11407_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fonc.2019.00104","volume":"9","author":"DG van Zyl","year":"2019","unstructured":"van Zyl DG, Mautner J, Delecluse H-J. Progress in EBV vaccines. Front Oncol. 2019;9:104.","journal-title":"Front Oncol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11407-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11407-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:36:07Z","timestamp":1757424967000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11407-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11407"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11407-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent to participate was unnecessary due to the retrospective nature of this study. Consequently, informed consent was waived by Jazan Health Cluster Ethics Committee, Saudi Arabia National Registration Number with NCBE-KACST, KSA: H-10-Z-141. The Ethical Approval Number is 2468 (date 14\/10\/2024). The study adheres to the Declaration of Helsinki, relevant international ethical guidelines, and Saudi national regulations for health research. During the data collection process, patient data were anonymized and handled confidentially to ensure privacy and compliance with institutional data protection protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1066"}}